Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061
2011 ◽
Vol 47
◽
pp. S231-S232
◽
2019 ◽
Vol 18
(3)
◽
pp. 183-191.e3
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. e19500-e19500
◽
2011 ◽
Vol 105
(10)
◽
pp. 1495-1502
◽
Keyword(s):
Keyword(s):